Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Adipotide

Prohibitin-targeting peptide 1 (Prohibitin-TP01)

Adipotide is a revolutionary experimental vascular-targeting peptidomimetic designed to induce selective apoptosis in blood vessels supplying white adipose tissue. Also known as Prohibitin-TP01, FTPP (Fat-Targeted Proapoptotic Peptide), or TP-1, it represents a completely novel approach to weight management through direct fat cell elimination rather than appetite suppression. While clinical development was discontinued in 2019 due to nephrotoxicity concerns, preclinical studies demonstrated remarkable efficacy with up to 30% weight reduction in rodent models and 11% weight loss in primate studies over just 28 days.

Adipotide Dosing Guide

What It's Used For

Adipotide is a synthetic peptide that targets fat cells by disrupting their blood supply, leading to targeted fat cell death. It works by binding to specific receptors (ANXA2 and prohibitin) found primarily on blood vessels supplying white adipose tissue.

Weight Loss and Fat Reduction

  • Reduces white adipose tissue by cutting off blood supply to fat cells
  • Promotes rapid weight loss through targeted fat cell apoptosis

Metabolic Health

  • Improves insulin sensitivity and glucose tolerance
  • Reduces insulin resistance markers

Body Composition

  • Decreases body mass index (BMI) and abdominal circumference
  • Targets visceral fat deposits linked to metabolic disorders

Diabetes Management Support

  • Shows potential for improving Type 2 diabetes markers
  • Enhances metabolic function through fat reduction

How Much to Take

Dose

0.01 mg per kg of body weight per day

  • For a 200 lb (90 kg) person: approximately 0.9 mg daily
  • For a 150 lb (68 kg) person: approximately 0.68 mg daily

How Often

  • Once daily subcutaneous injection
  • Consistent timing each day for optimal results

When to Inject

  • Inject at the same time each day (morning or evening)
  • Best administered on an empty stomach
  • Maintain consistent schedule throughout cycle

How Long to Use It

  • Cycle Length: Use for 28 days (4 weeks), followed by a break of 4-8 weeks
  • Protocol Variation: Some protocols suggest tapering doses in weeks 3-4
  • Repeat Cycles: Can be repeated after adequate break period if needed

Need-to-Know Information

How It Works

  • Binds to prohibitin and ANXA2 receptors on fat tissue blood vessels
  • Causes apoptosis (programmed death) of fat cells by cutting off blood supply
  • Specifically targets white adipose tissue while sparing brown fat

Key Benefits

  • Rapid Weight Loss: Studies show 11% body weight reduction in 28 days
  • Improved Insulin Sensitivity: Enhanced glucose metabolism
  • Targeted Fat Loss: Reduces visceral and subcutaneous fat
  • Metabolic Enhancement: Improved markers for Type 2 diabetes

Who Should Avoid It

  • Pregnant or breastfeeding individuals
  • Those with kidney disease or impaired kidney function
  • Individuals with cardiovascular conditions
  • Anyone with active cancer (consult doctor)

Possible Side Effects

  • Mild kidney function changes (usually reversible)
  • Nausea or decreased appetite
  • Injection site reactions
  • Dehydration risk
  • Temporary changes in electrolyte balance

How to Mix and Store It

Mixing Instructions

  • Use bacteriostatic water to reconstitute the peptide
  • Example: Add 2 mL of bacteriostatic water to a 10 mg vial
  • This creates a 5 mg/mL concentration
  • For a 0.9 mg dose, draw 0.18 mL into the syringe

Storage

  • Store mixed vials in the fridge at 2-8°C
  • Use within 28-30 days after reconstitution
  • Unmixed vials: Store in freezer at -20°C for long-term storage
  • Keep away from direct light

How to Inject

Injection Method

Where to Inject: Subcutaneous (under the skin) in fatty areas like stomach, thigh, or buttocks

Injection Tips:
  • Rotate injection sites daily to prevent irritation
  • Pinch skin fold and insert needle at 45-90 degree angle
  • Inject slowly and steadily
  • Clean injection site with alcohol swab before injecting

Example Dosing Schedule

Week 1-2

  • Full dose based on body weight (0.01 mg/kg)
  • Morning injection before breakfast

Week 3-4

  • Option to maintain full dose or taper to 0.5-0.75 of initial dose
  • Continue morning injection schedule

Post-Cycle

  • 4-8 week break before considering another cycle

Extra Tips for Best Results

Monitor Kidney Function

  • Consider baseline kidney function tests before starting
  • Watch for signs of dehydration or electrolyte imbalance
  • Stay well-hydrated throughout the cycle

Support Fat Loss

  • Maintain a balanced, nutrient-rich diet
  • Include moderate exercise to enhance results
  • Focus on protein intake to preserve lean muscle

Track Your Progress

  • Take weekly body measurements and photos
  • Monitor weight changes and body composition
  • Keep a log of any side effects or changes

Hydration is Key

  • Drink plenty of water throughout the cycle
  • Monitor urine color as hydration indicator
  • Consider electrolyte supplementation if needed

Start Conservative

  • Consider starting with a lower dose for the first few days
  • Gradually increase to full dose if well-tolerated
  • Stop immediately if severe side effects occur

Combine Wisely

  • Can potentially be stacked with other peptides after research
  • Avoid combining with other experimental compounds initially
  • Consult with knowledgeable practitioners about combinations

Medical Disclaimer

CRITICAL WARNING: Adipotide clinical development was permanently discontinued due to unacceptable nephrotoxicity. All human trials were terminated early. This information is for educational purposes only. Adipotide is NOT approved for any human use and carries severe kidney damage risks. Consult healthcare providers for approved weight management alternatives.